These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31771676)

  • 1. Implementing health technology assessment in Kuwait: a qualitative study of perceived barriers and facilitators.
    Darawsheh B; Germeni E
    Int J Technol Assess Health Care; 2019; 35(6):422-426. PubMed ID: 31771676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Requirements for and expectations of health technology assessment in Galicia (Spain). A qualitative study from the perspective of decision-makers and clinicians].
    Varela-Lema L; Merino GA; García ML; Martínez MV; Triana EG; Mota TC
    Gac Sanit; 2011; 25(6):454-60. PubMed ID: 21820766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EMERGENCE OF "DRIVERS" FOR THE IMPLEMENTATION OF HEALTH TECHNOLOGY ASSESSMENT.
    Castro Jaramillo HE; Moreno-Mattar O; Osorio-Cuevas D
    Int J Technol Assess Health Care; 2016 Jan; 32(4):300-306. PubMed ID: 27691993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The implementation of HTA in medicine pricing and reimbursement policies in Indonesia: Insights from multiple stakeholders.
    Wasir R; Irawati S; Makady A; Postma M; Goettsch W; Feenstra T; Buskens E
    PLoS One; 2019; 14(11):e0225626. PubMed ID: 31774854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAKEHOLDER INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT AT NATIONAL LEVEL: A STUDY FROM IRAN.
    Yazdizadeh B; Shahmoradi S; Majdzadeh R; Doaee S; Bazyar M; Souresrafil A; Olyaeemanesh A
    Int J Technol Assess Health Care; 2016 Jan; 32(3):181-9. PubMed ID: 27524462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Culture, Values, and Politics in the Implementation of Health Technology Assessment in India: A Commentary.
    Swami S; Srivastava T
    Value Health; 2020 Jan; 23(1):39-42. PubMed ID: 31952672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A qualitative study on the feasibility and acceptability of institutionalizing health technology assessment in Malawi.
    Mfutso-Bengo J; Jeremiah F; Kasende-Chinguwo F; Ng'ambi W; Nkungula N; Kazanga-Chiumia I; Juma M; Chawani M; Chinkhumba J; Twea P; Chirwa E; Langwe K; Manthalu G; Ngwira LG; Nkhoma D; Colbourn T; Revill P; Sculpher M
    BMC Health Serv Res; 2023 Apr; 23(1):353. PubMed ID: 37041590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FRAMEWORK FOR USER INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT AT THE LOCAL LEVEL: VIEWS OF HEALTH MANAGERS, USER REPRESENTATIVES, AND CLINICIANS.
    Gagnon MP; Desmartis M; Gagnon J; St-Pierre M; Rhainds M; Coulombe M; Tantchou MD; Légaré F
    Int J Technol Assess Health Care; 2015 Jan; 31(1-2):68-77. PubMed ID: 25952585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health Technology Assessment Development in Vietnam: A Qualitative Study of Current Progress, Barriers, Facilitators, and Future Strategies.
    Lee HY; Nguyen TT; Park S; Hoang VM; Kim WH
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'The problem is small enough, the problem is big enough': a qualitative study of health technology assessment and public policy on drug funding decisions for children.
    Denburg AE; Giacomini M; Ungar WJ; Abelson J
    Int J Equity Health; 2020 Mar; 19(1):45. PubMed ID: 32228588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing institutionalization of health technology assessment in Kenya.
    Mbau R; Vassall A; Gilson L; Barasa E
    BMC Health Serv Res; 2023 Jun; 23(1):681. PubMed ID: 37349812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An exploration of patient safety culture in Kuwait hospitals: a qualitative study of healthcare professionals' perspectives.
    Al Hamid A; Malik A; Alyatama S
    Int J Pharm Pract; 2020 Dec; 28(6):617-625. PubMed ID: 31468591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers and facilitators influencing ethical evaluation in health technology assessment.
    Assasi N; Schwartz L; Tarride JE; O'Reilly D; Goeree R
    Int J Technol Assess Health Care; 2015 Jan; 31(3):113-23. PubMed ID: 26179275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT IN IRAN.
    Mohtasham F; Majdzadeh R; Jamshidi E
    Int J Technol Assess Health Care; 2017 Jan; 33(4):529-533. PubMed ID: 28814351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INTEGRATE-HTA: A LOW- AND MIDDLE-INCOME COUNTRY PERSPECTIVE.
    Bijlmakers L; Mueller D; Kahveci R; Chen Y; van der Wilt GJ
    Int J Technol Assess Health Care; 2017 Jan; 33(5):599-604. PubMed ID: 29103380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and Facilitators of Using R for Decision Analytic Modeling in Health Technology Assessment: Focus Group Results.
    Marks Y; Hoch JS; Heath A; Pechlivanoglou P
    Pharmacoeconomics; 2024 Jul; 42(7):783-795. PubMed ID: 38607519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Who's afraid of institutionalizing health technology assessment (HTA)?: Interests and policy positions on HTA in the Czech Republic.
    Löblová O
    Health Econ Policy Law; 2018 Apr; 13(2):137-161. PubMed ID: 29108525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A SWOT analysis of the development of health technology assessment in Iran.
    Behzadifar M; Ghanbari MK; Azari S; Bakhtiari A; Rahimi S; Ehsanzadeh SJ; Sharafkhani N; Moridi S; Bragazzi NL
    PLoS One; 2023; 18(3):e0283663. PubMed ID: 36996128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Most important barriers and facilitators of HTA usage in decision-making in Europe.
    Cheung KL; Evers SMAA; De Vries H; Levy P; Pokhrel S; Jones T; Danner M; Wentlandt J; Knufinke L; Mayer S; Hiligsmann M
    Expert Rev Pharmacoecon Outcomes Res; 2018 Jun; 18(3):297-304. PubMed ID: 29303374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.